192 related articles for article (PubMed ID: 19738066)
1. Contribution of granulocyte colony-stimulating factor to the acute mobilization of endothelial precursor cells by vascular disrupting agents.
Shaked Y; Tang T; Woloszynek J; Daenen LG; Man S; Xu P; Cai SR; Arbeit JM; Voest EE; Chaplin DJ; Smythe J; Harris A; Nathan P; Judson I; Rustin G; Bertolini F; Link DC; Kerbel RS
Cancer Res; 2009 Oct; 69(19):7524-8. PubMed ID: 19738066
[TBL] [Abstract][Full Text] [Related]
2. Low-dose metronomic cyclophosphamide combined with vascular disrupting therapy induces potent antitumor activity in preclinical human tumor xenograft models.
Daenen LG; Shaked Y; Man S; Xu P; Voest EE; Hoffman RM; Chaplin DJ; Kerbel RS
Mol Cancer Ther; 2009 Oct; 8(10):2872-81. PubMed ID: 19825805
[TBL] [Abstract][Full Text] [Related]
3. Reversing resistance to vascular-disrupting agents by blocking late mobilization of circulating endothelial progenitor cells.
Taylor M; Billiot F; Marty V; Rouffiac V; Cohen P; Tournay E; Opolon P; Louache F; Vassal G; Laplace-Builhé C; Vielh P; Soria JC; Farace F
Cancer Discov; 2012 May; 2(5):434-49. PubMed ID: 22588881
[TBL] [Abstract][Full Text] [Related]
4. Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents.
Shaked Y; Henke E; Roodhart JM; Mancuso P; Langenberg MH; Colleoni M; Daenen LG; Man S; Xu P; Emmenegger U; Tang T; Zhu Z; Witte L; Strieter RM; Bertolini F; Voest EE; Benezra R; Kerbel RS
Cancer Cell; 2008 Sep; 14(3):263-73. PubMed ID: 18772115
[TBL] [Abstract][Full Text] [Related]
5. Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors.
Shaked Y; Ciarrocchi A; Franco M; Lee CR; Man S; Cheung AM; Hicklin DJ; Chaplin D; Foster FS; Benezra R; Kerbel RS
Science; 2006 Sep; 313(5794):1785-7. PubMed ID: 16990548
[TBL] [Abstract][Full Text] [Related]
6. Granulocyte colony-stimulating factor (G-CSF) depresses angiogenesis in vivo and in vitro: implications for sourcing cells for vascular regeneration therapy.
Tura O; Crawford J; Barclay GR; Samuel K; Hadoke PW; Roddie H; Davies J; Turner ML
J Thromb Haemost; 2010 Jul; 8(7):1614-23. PubMed ID: 20456757
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous and granulocyte–colony-stimulating factor-enhanced marrow response and progenitor cell mobilization in mice after myocardial infarction.
Delgaudine M; Gothot A; Beguin Y
Cytotherapy; 2010 Nov; 12(7):909-18. PubMed ID: 20230223
[TBL] [Abstract][Full Text] [Related]
8. Redefining the target again: chemotherapeutics as vascular disrupting agents?
Gokmen-Polar Y; Miller KD
Cancer Cell; 2008 Sep; 14(3):195-6. PubMed ID: 18772108
[TBL] [Abstract][Full Text] [Related]
9. Combined effects of hematopoietic progenitor cell mobilization from bone marrow by granulocyte colony stimulating factor and AMD3100 and chemotaxis into the brain using stromal cell-derived factor-1α in an Alzheimer's disease mouse model.
Shin JW; Lee JK; Lee JE; Min WK; Schuchman EH; Jin HK; Bae JS
Stem Cells; 2011 Jul; 29(7):1075-89. PubMed ID: 21608078
[TBL] [Abstract][Full Text] [Related]
10. Degradation of BM SDF-1 by MMP-9: the role in G-CSF-induced hematopoietic stem/progenitor cell mobilization.
Jin F; Zhai Q; Qiu L; Meng H; Zou D; Wang Y; Li Q; Yu Z; Han J; Li Q; Zhou B
Bone Marrow Transplant; 2008 Nov; 42(9):581-8. PubMed ID: 18679363
[TBL] [Abstract][Full Text] [Related]
11. Phase I trial of combretastatin A4 phosphate (CA4P) in combination with bevacizumab in patients with advanced cancer.
Nathan P; Zweifel M; Padhani AR; Koh DM; Ng M; Collins DJ; Harris A; Carden C; Smythe J; Fisher N; Taylor NJ; Stirling JJ; Lu SP; Leach MO; Rustin GJ; Judson I
Clin Cancer Res; 2012 Jun; 18(12):3428-39. PubMed ID: 22645052
[TBL] [Abstract][Full Text] [Related]
12. Effects of granulocyte colony simulating factor on functional activities of endothelial progenitor cells in patients with chronic ischemic heart disease.
Honold J; Lehmann R; Heeschen C; Walter DH; Assmus B; Sasaki K; Martin H; Haendeler J; Zeiher AM; Dimmeler S
Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2238-43. PubMed ID: 16902165
[TBL] [Abstract][Full Text] [Related]
13. Impact of enhanced mobilization of bone marrow derived cells to site of injury.
Hannoush EJ; Sifri ZC; Elhassan IO; Mohr AM; Alzate WD; Offin M; Livingston DH
J Trauma; 2011 Aug; 71(2):283-9; discussion 289-91. PubMed ID: 21825928
[TBL] [Abstract][Full Text] [Related]
14. Liver surgery induces an immediate mobilization of progenitor cells in liver cancer patients: A potential role for G-CSF.
Langenberg MH; Nijkamp MW; Roodhart JM; Snoeren N; Tang T; Shaked Y; van Hillegersberg R; Witteveen PO; Vermaat JS; Kranenburg O; Kerbel RS; Medema RH; Borel Rinkes IH; Voest EE
Cancer Biol Ther; 2010 May; 9(9):743-8. PubMed ID: 20215863
[TBL] [Abstract][Full Text] [Related]
15. Plasma levels of stromal cell-derived factor-1 (CXCL12) and circulating endothelial progenitor cells in women with idiopathic heavy menstrual bleeding.
Elsheikh E; Andersson E; Sylvén C; Ericzon BG; Palmblad J; Mints M
Hum Reprod; 2014 Jan; 29(1):49-56. PubMed ID: 24218400
[TBL] [Abstract][Full Text] [Related]
16. Parathyroid hormone effectively induces mobilization of progenitor cells without depletion of bone marrow.
Brunner S; Zaruba MM; Huber B; David R; Vallaster M; Assmann G; Mueller-Hoecker J; Franz WM
Exp Hematol; 2008 Sep; 36(9):1157-66. PubMed ID: 18504066
[TBL] [Abstract][Full Text] [Related]
17. Flt3 ligand synergizes with granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor to mobilize hematopoietic progenitor cells into the peripheral blood of mice.
Brasel K; McKenna HJ; Charrier K; Morrissey PJ; Williams DE; Lyman SD
Blood; 1997 Nov; 90(9):3781-8. PubMed ID: 9345066
[TBL] [Abstract][Full Text] [Related]
18. Stromal-derived factor 1 and matrix metalloproteinase 9 levels in bone marrow and peripheral blood of patients mobilized by granulocyte colony-stimulating factor and chemotherapy. Relationship with mobilizing capacity of haematopoietic progenitor cells.
Carion A; Benboubker L; Hérault O; Roingeard F; Degenne M; Senecal D; Desbois I; Colombat P; Charbord P; Binet C; Domenech J
Br J Haematol; 2003 Sep; 122(6):918-26. PubMed ID: 12956762
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stromal cells induce a permissive state in the bone marrow that enhances G-CSF-induced hematopoietic stem cell mobilization in mice.
de Kruijf EFM; Zuijderduijn R; Stip MC; Fibbe WE; van Pel M
Exp Hematol; 2018 Aug; 64():59-70.e2. PubMed ID: 29775645
[TBL] [Abstract][Full Text] [Related]
20. Enhanced antitumor efficacy of a vascular disrupting agent combined with an antiangiogenic in a rat liver tumor model evaluated by multiparametric MRI.
Chen F; Feng Y; Zheng K; De Keyzer F; Li J; Feng Y; Cona MM; Wang H; Jiang Y; Yu J; Marchal G; Verfaillie C; De Geest B; Oyen R; Ni Y
PLoS One; 2012; 7(7):e41140. PubMed ID: 22815943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
